Member Info for alfista

Sphinx. Provexis don't make anything, the capsules are produced, and also marketed under other brand names, by a specialist factory. I can't believe they wouldn't have anticipated scalability in their production process.

The conventional business model would suggest not IMHO. Normally new product launches put at least part of the financial burden on the supplier, so both DSM as the supplier of Fruitflow, and Provexis as the supplier of the finished product, (possibly also the manufacturer of the capsules), would need to contribute.
Of course we have no way of knowing if a conventional model is being followed. Nor do we know how the sales direct by Provexis, or the profit share contribution from DSM, have been affecting cash reserves over the last year. The only hint being that no more funds have been called for, much to the ire of Les Miserables.
My own opinion is that, if funds are called for to support a much bigger stockholding to supply a much bigger potential market, the they'd have no issues in raising them. If it proves to be self funding, I'd be surprised and delighted.

It would be really good if a line could be drawn under Sirco.
It was a test product for the syrup form of Fruitflow. Neither that ingredient, nor the drink, has proven to be the acceptable delivery method for Fruitflow. The very first update after the signing of the AA with DSM recognised that very clearly. Ned Ludd died a while back folks, he was spectacularly unsuccessful with his point of view.

Very welcome confirmation of news that Gixer discovered last week.
Hopefully more retailers will follow Holland & Barret, as awareness of Fruitflow expands it will push open more doors IMHO.
A significant step, Provexis retail revenues becoming a highly important part of the equation.

Some seem positively upset. I can't understand that. 6-1 to the optimists today.

In response to a bit of optimism on the other site, Percy wrote

"Wheelds - do you really think that anyone anywhere is likely to buy a tablet to combat bad air pollution?"

In a word, Yes.
Unbelievably naïve to ignore how seriously city dwellers regard their health. As an example, air pollution levels are prominently displayed, and broadcast on media, every day of the year in Shanghai. Dwellers then decide their activities in order to minimise exposure. Air conditioning is as much about filtration as temperature control. Many already take various products daily
Would another product, backed by a patent and published health claims, have a commercial chance in every city of the world?
I think I'll regard that question as rhetorical.

I know it's off topic here, but I have my opinion on hydrogen. I know you're invested so won't labour the point, mine in Acta gave me a good return, though subsequently they went under. Worth noting that particulate emissions come from all types of friction, tyres, brakes, motors. So it won't disappear even in a zero deisel environment. I'm lucky to live in clean countryside, but Fruitflow has several health claims that fully apply to me.

I know it's off topic here, but I have my opinion on hydrogen. I know you're invested so won't labour the point, mine in Acta gave me a good return, though subsequently they went under. Worth noting that particulate emissions come from all types of friction, tyres, brakes, motors. So it won't disappear even in a zero deisel environment. I'm lucky to live in clean countryside, but Fruitflow has several health claims that fully apply to me.

Battery yes, although there is airborn particulate emission from both the motor and braking, given the extra weight the braking emission is higher than a conventional vehicle. Hydrogen, not a chance IMHO, unless they can re invent the storage vessels, current pressures are lethal.

The list of references at the foot of that report, many involving Dr Niamh, is impressive. Study after study arriving at the conclusion that Fruitflow is beneficial to cardio vascular health. That's how medical advocacy works. Good find there sphinx

Fair point. I think the word "edit" may be an explanation. Readers who are interested may then visit Dr Sarah's website. Hope so.

The discount is solely for pre=payment, it isn't their gross profit on sales, just an additional bit if they are cashed up and willing to pay up front. The cost to Provexis to supply the stores, presumably outsourced to the same logistics company, shouldn't be a large part of the overall margin, the benefit of having small, light, packaging.. Hugely less than MM would have had to pay to transport Sirco.

The obvious answer is that we have no way of knowing. In this era of ultra low return on money left with the bank, some companies have paid up front in order to get a discount. Makes sense to take 2-3% ( that is the typical rate in the industry I work in). On the other hand, payment on SoR, or extended payment terms, are still demanded by bigger companies. Provexis will have to supply back up stock in order to maintain continuity of availability, that is a normal trade risk. More funds for inventory may be required, although DSM could also share in the risk, as could the manufacturer of the capsules. Complexity will increase if more retail is added, but rising revenues will also make other forms of funding feasible, invoice factoring etc. Interesting to watch developments

A global?

It has to help in making target consumers more aware doesn't it. H&B are living proof that a large sector of the population are prepared to take an active role in their own health and wellbeing, and pay for it. This morning's news featured cardiovascular health being a key to fighting dementia. Fruitflow directly addresses this.

Further encouraging progress from the Company's Fruitflow® + Omega-3 dietary supplement product which was launched in 2016. Listing with Amazon secured in June 2017, further UK sales channel opportunities are currently being progressed to include listings with some major UK retailers; the Company is actively seeking to launch the product online into wider international markets to include North America.

Says "Out of stock" Surprising that they use Provexis in the description, any online searcher can save over their price. Pumpky. Sirco was a first go, the taste was not mainstream, the packs were bulky and easily damaged, logistics costly and a nightmare. From the moment a tablet format became feasible, Sirco was a dodo.

A logical progression from the various medical professional's blogs. Retail has so many channels these days

A welcome reversal, but not enough volume to be significant yet IMHO

Last year, post year end, we got an update, along with an invitation to join in a two part fund raising, part one had been fully subscribed to by investors. This year, post year end, we have had no update. Logic would suggest to me that this means funds are not an issue at this time, giving lie to those who post headless chicken posts that funds have run out. Fully concur with Kievsky.

Looks like a bit more liquidity of late, trades in both directions. Seems to be a change happened on the other site, now you have to register before being able to view anything. So Les Miserables can say what they like, won't see it. so long folks, it's been, ermm�..